Helena Kopp Kallner

About me
Publications
CV
Public outreach and news

About me

Helena Kopp Kallner is senior lecturer and associate professor at Karolinska
Institutet in Sweden and senior consultant in Obstetrics and Gynecology at
Danderyd Hospital.
She is head of the clinical research department and clinical trials unit at
the department of Obstetrics and Gynecology at Danderyd Hospital. Her
research group focuses on research in the field of contraception, abortion
and fibroids in addition to obstetrics.
She is principal investigator of several ongoing academic as well as
sponsored clinical trials. The methods encompass translational research to
clinical studies and epidemiology.
She is president of the working group on family planning in Sweden and
president of the European Society of Contraception and Reproductive health.
She is a frequent lecturer on the subject of abortion, contraception and
treatment of fibroids.

Articles

Article: JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2024;44(1):2337687
Time to pregnancy recognition among users of an FDA-cleared fertility application
van Lamsweerde A; Pearson JT; Urrutia R; Gemzell-Danielsson K; Kopp Kallner H; Nelson A; Benhar E; Favaro C; Scherwitzl EB; Scherwitzl R
Article: NEW ENGLAND JOURNAL OF MEDICINE. 2024;391(18):1685-1695
Randomized Trial of Very Early Medication Abortion
Brandell K; Jar-Allah T; Reynolds-Wright J; Kallner HK; Hognert H; Gyllenberg F; Kaislasuo J; Tamang A; Tuladhar H; Boerma C; Schimanski K; Gibson G; Lokeland M; Teleman P; Bixo M; Kjaer MM; Kallfa E; Bring J; Heikinheimo O; Cameron S; Gemzell-Danielsson K
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(11):2242-2251
Effects of structured contraceptive counseling in young women: Secondary analyses of a cluster randomized controlled trial (the LOWE trial)
Iwarsson KE; Podolskyi V; Bizjak I; Kallner HK; Gemzell-Danielsson K; Envall N
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2024;231(5):524.e1-524.e7
Mepivacaine instillation for pain reduction during intrauterine device placement in nulliparous women: a double-blinded randomized trial
Envall N; Elgemark K; Kallner HK
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2024;231(5):530.e1-530.e8
Placement of an intrauterine device within 48 hours after second-trimester medical abortion: a randomized controlled trial
Hogmark S; Rydelius J; Envall N; Teleman P; Gemzell-Danielsson K; Kallner HK
Article: BJOG: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2024
Misoprostol as Oral Solution or Oral Tablet for Induction of Labour (MISOBEST): A Randomised Controlled Non-Inferiority Trial
Svensk E; Bessfelt E; Wendel SB; Kallner HK; Wallstroem T
Article: BMJ OPEN. 2024;14(10):e082749
Breast and endometrial safety of micronised progesterone versus norethisterone acetate in menopausal hormone therapy (PROBES): study protocol of a double-blind randomised controlled trial
Lundell C; Stergiopoulos N; Blomberg L; Ujvari D; Schuppe-Koistinen I; Kopp-Kallner H; Iliadis SI; Skalkidou A; Hirschberg AL
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2024;29(5):239-244
Postpartum contraception provision across Europe: preliminary findings from a multi country survey
Cooper M; Gemzell-Danielsson K; Kopp-Kallner H; Heikinheimo O; Cameron S
Article: THE LANCET. 2024;404(10455):864-873
First dose of misoprostol administration at home or in hospital for medical abortion between 12-22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial
Rydelius J; Hognert H; Kopp-Kallner H; Brandell K; Romell J; Zetterstrom K; Teleman P; Gemzell-Danielsson K
Article: THE BMJ. 2024;385:e079014
Lateral episiotomy or no episiotomy in vacuum assisted delivery in nulliparous women (EVA): multicentre, open label, randomised controlled trial
Bergendahl S; Jonsson M; Hesselman S; Ankarcrona V; Leijonhufvud A; Wihlback A-C; Wallstrom T; Rydstrom E; Friberg H; Kallner HK; Wendel SB
Article: JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY. 2024;65(6):832-844
Time after time: failure to identify and support females with ADHD - a Swedish population register study
Skoglund C; Poromaa IS; Leksell D; Selling KE; Cars T; Giacobini M; Young S; Kallner HK
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(6):1224-1230
The outcomes of team-based learning versus small group interactive learning in the obstetrics and gynecology course for undergraduate students
Sterpu I; Herling L; Nordquist J; Moller A; Kallner HK; Engberg H; Acharya G
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(5):873-883
Contraceptive uptake and compliance after structured contraceptive counseling - secondary outcomes of the LOWE trial
Bizjak I; Envall N; Emtell Iwarsson K; Kopp Kallner H; Gemzell-Danielsson K
Article: BMJ SEXUAL AND REPRODUCTIVE HEALTH. 2024;50(2):107-113
Women's experiences of postpartum contraceptive services when elective caesarean section is the method of birth: a qualitative study
Liljeblad KL; Kallner HK; Brynhildsen J; Kilander H
Article: BMC MEDICINE. 2024;22(1):84
Estrogen-modulating treatment among mid-life women and COVID-19 morbidity and mortality: a multiregister nationwide matched cohort study in Sweden
Elenis E; Kallner HK; Karalexi MA; Haegg D; Linder M; Fall K; Papadopoulos FC; Skalkidou A
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2024;103(1):59-67
Incidence of stillbirth among women with different risk profiles in Stockholm 2001-2020: a repeated cross-sectional study
Lunden M; Varli IH; Kallner HK; Amark H
Article: CURRENT OPINION IN OBSTETRICS AND GYNECOLOGY. 2023;35(6):490-495
Medical abortion in the second trimester - an update
Kopp Kallner H
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2023;102(12):1694-1702
One-year follow up of contraceptive use and pregnancy rates after early medical abortion: Secondary outcomes from a randomized controlled trial of immediate post-abortion placement of intrauterine devices
Hogmark S; Envall N; Gemzell-Danielsson K; Kallner HK
Article: INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY. 2023;193:112230
Levonorgestrel intrauterine device and depression: A Swedish register-based cohort study
Stenhammar E; Wikman P; Danielsson KG; Kopp-Kallner H; Poromaa IS
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2023;28(5):275-281
The use and access to contraception in Sweden during the COVID-19 pandemic period
Envall N; Danielsson KG; Kallner HK
Article: JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. 2023;62(6):665-674
Hormonal Contraceptive Use and Risk of Depression Among Young Women With Attention-Deficit/Hyperactivity Disorder
Lundin C; Wikman A; Wikman P; Kallner HK; Sundstrom-Poromaa I; Skoglund C
Article: NATURE NEUROSCIENCE. 2023;26(5):891-901
Profiling spatiotemporal gene expression of the developing human spinal cord and implications for ependymoma origin
Li X; Andrusivova Z; Czarnewski P; Langseth CM; Andersson A; Liu Y; Gyllborg D; Braun E; Larsson L; Hu L; Alekseenko Z; Lee H; Avenel C; Kallner HK; Akesson E; Adameyko I; Nilsson M; Linnarsson S; Lundeberg J; Sundstrom E
Article: HUMAN MOLECULAR GENETICS. 2023;32(7):1063-1071
Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate
Kolterud A; Valimaki N; Kuisma H; Patomo J; Ilves ST; Makinen N; Kaukomaa J; Palin K; Kaasinen E; Karhu A; Pasanen A; Butzow R; Heikinheimo O; Kallner HK; Aaltonen LA
Article: BMC WOMEN'S HEALTH. 2023;23(1):105
Development of a brief menstrual quality of life measure for women with heavy menstrual bleeding
Lancastle D; Kallner HK; Hale G; Wood B; Ashcroft L; Driscoll H
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2023;28(1):1-9
Bleeding profile satisfaction and pain and ease of placement with levonorgestrel 19.5 my IUD: findings from the Kyleena® Satisfaction study
Donders G; Kallner HK; Hauck B; Bauerfeind A; Frenz A-K; Zvolanek M; Stovall DW
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2023;228(1):53.e1-53.e9
Placement of an intrauterine device within 48 hours after early medical abortion-a randomized controlled trial
Hogmark S; Liljeblad KL; Envall N; Gemzell-Danielsson K; Kallner HK
Article: INTERNATIONAL JOURNAL OF HYPERTHERMIA. 2022;39(1):1158-1163
Long term follow-up of uterine fibroids treated with microwave ablation: an up to 3-year observational study of volume, regrowth, and symptoms
Beermann M; Jonsdottir G; Cronisoe A; Hasselrot K; Kallner HK
Article: INTERNATIONAL JOURNAL OF HYPERTHERMIA. 2022;39(1):341-347
Ultrasound guided microwave ablation compared to uterine artery embolization treatment for uterine fibroids - a randomized controlled trial
Jonsdottir G; Beermann M; Cronsioe AL; Hasselrot K; Kallner HK
Article: SCIENTIFIC REPORTS. 2022;12(1):17402
Interpregnancy interval and maternal and neonatal morbidity: a nationwide cohort study
Muhlrad H; Bjorkegren E; Haraldson P; Bohm-Starke N; Kallner HK; Wendel SB
Article: THE LANCET REGIONAL HEALTH. EUROPE. 2022;21:100470
Hormonal contraception and risk of breast cancer and breast cancer in situ among Swedish women 15-34 years of age: A nationwide register-based study
Hultstrand JN; Gemzell-Danielsson K; Kallner HK; Lindman H; Wikman P; Sundstrom-Poromaa I
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2022;27(5):409-417
Use of contraception and attitudes towards contraceptive use in Swedish women: an internet-based nationwide survey
Envall N; Wallstrom T; Danielsson KG; Kallner HK
Article: SEXUAL AND REPRODUCTIVE HEALTHCARE. 2022;33:100763
Development of a tool to analyse what resources are needed to implement a midwife-led care framework- the MIDWIZE conceptual framework
Erlandsson K; Lindgren H; Kallner HK; Aden U; Friberg IO; Elinder LS; Hajeebhoy N; Gemzell-Danielsson K
Article: OBSTETRICS AND GYNECOLOGY. 2022;140(2):227-233
The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy
Elgemark K; Graner S; McTaggart J; Lofstrom JR; Sorensen D; Envall N; Kallner HK
Article: SEXUAL AND REPRODUCTIVE HEALTHCARE. 2022;32:100727
Knowledge, challenges, and standard of care of young women with ADHD at Swedish youth clinics
Carlander A-KK; Thorsell M; Demetry Y; Nikodell S; Kallner HK; Skoglund C
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2022;27(3):261-264
Migration of a subdermal contraceptive implant into a subsegmental pulmonary artery and etonogestrel serum concentration over time - a case report
Mallak FK; Kallner HK
Article: OBSTETRICS AND GYNECOLOGY. 2022;139(5):764-770
Method of Hormonal Contraception and Protective Effects Against Ectopic Pregnancy
Kopp-Kallner H; Linder M; Cesta CE; Chacon SS; Kieler H; Graner S
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2022;101(4):424-430
Effectiveness, safety and overall satisfaction of early postpartum placement of hormonal IUD compared with standard procedure: An open-label, randomized, multicenter study
Liljeblad KL; Kallner HK; Brynhildsen J
Article: BMJ SEXUAL AND REPRODUCTIVE HEALTH. 2022;48(2):128-136
Long-acting reversible contraception and satisfaction with structured contraceptive counselling among non-migrant, foreign-born migrant and second-generation migrant women: evidence from a cluster randomised controlled trial (the LOWE trial) in Sweden
Iwarsson KE; Larsson EC; Bizjak I; Envall N; Kallner HK; Gemzell-Danielsson K
Article: BMC WOMEN'S HEALTH. 2022;22(1):35
Prevalence and correlates of current suicidal ideation in women with premenstrual dysphoric disorder
Wikman A; Sacher J; Bixo M; Hirschberg AL; Kallner HK; Epperson CN; Comasco E; Poromaa IS
Article: EUROPEAN JOURNAL OF OBSTETRICS AND GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2022;269:62-70
Attitudes and knowledge regarding episiotomy use and technique in vacuum extraction: A web-based survey among doctors in Sweden
Ankarcrona V; Hesselman S; Kallner HK; Wendel SB
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2022;101(1):77-83
Provision of long-acting reversible contraception at surgical abortion-A cross-sectional nationwide register study
Hogmark S; Envall N; Wikman A; Skoglund C; Kallner HK; Hesselman S
Article: BMJ SEXUAL AND REPRODUCTIVE HEALTH. 2022;48(1):41-46
Intendedness of pregnancies and preconception contraceptive use in women of Swedish and non-European origins seeking emergency care in early pregnancy
Bergman M; Gray A-M; Sollier N; Sjostrand M; Kopp Kallner H
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2021;26(6):462-472
Satisfaction and continuation with LNG-IUS 12: findings from the real-world kyleena(R) satisfaction study
Stovall DW; Aqua K; Roemer T; Donders G; Sordal T; Hauck B; de la Llata ES; Kallner HK; Salomon J; Zvolanek M; Frenz A-K; Boehnke T; Bauerfeind A
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2021;100(11):2044-2052
Evaluation of satisfaction with a model of structured contraceptive counseling: Results from the LOWE trial
Envall N; Iwarsson KE; Bizjak I; Danielsson KG; Kallner HK
Article: BJOG: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2021;128(9):1546-1554
Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial)
Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K
Article: JOURNAL OF WOMEN'S HEALTH. 2021;30(6):782-788
Contraceptive Effectiveness of an FDA-Cleared Birth Control App: Results from the Natural Cycles US Cohort
Pearson JT; Chelstowska M; Rowland SP; Benhar E; Kopp-Kallner H; Scherwitzl EB; Acuna J; Danielsson KG; Scherwitzl R
Article: CONTRACEPTION. 2021;103(4):261-264
Adherence to Swedish national recommendations for long acting reversible contraceptive provision at the time of medical abortion
Egardt A; Algovik M; Kallner HK
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2021;178(3):256-265
Ulipristal Acetate for Treatment of Premenstrual Dysphoric Disorder: A Proof-of-Concept Randomized Controlled Trial
Comasco E; Kallner HK; Bixo M; Hirschberg AL; Nyback S; de Grauw H; Epperson CN; Sundstrom-Poromaa I
Article: BJOG: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2020;127(12):1480-1487
Association of maternal attention deficit hyperactivity disorder and preterm birth: a cohort study
Hesselman S; Wikman A; Skoglund C; Kopp Kallner H; Skalkidou A; Sundstrom-Poromaa I; Wikstrom A-K
Article: OBESITY SURGERY. 2020;30(6):2217-2224
Pharmacokinetics of Oral Levonorgestrel in Women After Roux-en-Y Gastric Bypass Surgery and in BMI-Matched Controls
Ginstman C; Kopp Kallner H; Fagerberg-Silwer J; Carlsson B; Arlemalm A; Bottiger Y; Brynhildsen J
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2020;25(3):182-189
Insertion experience of women and health care professionals in the Kyleena^® Satisfaction Study
Beckert V; Aqua K; Bechtel C; Cornago S; Kallner HK; Schulze A; Parashar P; Waddington A; Donders G
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2020;99(4):488-493
Efficacy of mifepristone and misoprostol for medical treatment of missed miscarriage in clinical practice-A cohort study
Ehrnsten L; Altman D; Ljungblad A; Kallner HK
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2020;25(2):147-150
Contraceptive use at the time of and after an ectopic pregnancy: a retrospective cohort study
Nordstrom F; McTaggart J; Melander E; Altman D; Kopp Kallner H
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2020;25(2):141-146
Risk of abortion within 1-2 years after childbirth in relation to contraceptive choice: a retrospective cohort study
Lichtenstein Liljeblad K; Kopp Kallner H; Brynhildsen J
Article: JAMA NETWORK OPEN. 2019;2(10):e1912463
Association of Attention-Deficit/Hyperactivity Disorder With Teenage Birth Among Women and Girls in Sweden
Skoglund C; Kallner HK; Skalkidou A; Wikstrom A-K; Lundin C; Hesselman S; Wikman A; Poromaa IS
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2019;24(4):260-265
Short- and long-term effect of contraceptive methods on fecundity
Scherwitzl EB; Lundberg O; Kallner HK; Rowland SP; Holte J; Trussell J; Danielsson KG; Scherwitzl R
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2019;98(7):937-943
Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy
Graner S; Mc Taggart J; Nordstrom F; Melander E; Widenberg J; Kallner HK
Article: CONTRACEPTION. 2019;99(6):335-339
Intrauterine mepivacaine instillation for pain relief during intrauterine device insertion in nulliparous women: a double-blind, randomized, controlled trial
Envall N; Lagercrantz HG; Sunesson J; Kallner HK
Article: BMJ OPEN. 2019;9(3):e025050
Lateral episiotomy versus no episiotomy to reduce obstetric anal sphincter injury in vacuum-assisted delivery in nulliparous women: study protocol on a randomised controlled trial
Bergendahl S; Ankarcrona V; Leijonhufvud A; Hesselman S; Karlstrom S; Kallner HK; Wendel SB
Article: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2019;24(2):154-160
Trends in use and attitudes towards contraception in Sweden: results of a nationwide survey
Hellstrom A; Danielsson KG; Kallner HK
Article: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 2019;84(5):472-476
Urodynamics as a Prognosticator of Mirabegron Treatment Outcomes
Kallner HK; Elmer C; Aitman D
Article: HUMAN REPRODUCTION. 2018;33(11):2002-2009
Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial
Papaikonomou K; Kallner HK; Soderdahl F; Gemzell-Danielsson K
Article: BMC WOMEN'S HEALTH. 2018;18(1):89
Colposcopy telemedicine: live versus static swede score and accuracy in detecting CIN2+, a cross-sectional pilot study
Taghavi K; Banerjee D; Mandal R; Kallner HK; Thorsell M; Friis T; Kocoska-Maras L; Strander B; Singer A; Wikstrom E
Article: CONTRACEPTION. 2018;97(5):445-450
Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usage
Engstrand S; Kallner HK
Article: SCIENTIFIC REPORTS. 2018;8(1):4549
Imaging single DNA molecules for high precision NIPT
Dahl F; Ericsson O; Karlberg O; Karlsson F; Howell M; Persson F; Roos F; Stenberg J; Ahola T; Alftren I; Andersson B; Barkenas E; Brandner B; Dahlberg J; Elfman S; Eriksson M; Forsgren P-O; Francois N; Gousseva A; Hakamali F; Janfalk-Carlsson A; Johansson H; Lundgren J; Mohsenchian A; Olausson L; Olofsson S; Qureshi A; Skarpas B; Savneby A; Astrom E; Ohman O; Westgren M; Kopp-Kallner H; Fianu-Jonasson A; Syngelaki A; Nicolaides K
Article: PLOS ONE. 2018;13(6):e0197958
Investigating the loss of work productivity due to symptomatic leiomyoma
Hasselrot K; Lindeberg M; Konings P; Kallner HK
Article: CONTRACEPTION. 2017;96(6):420-425
Perfect-use and typical-use Pearl Index of a contraceptive mobile app
Scherwitzl EB; Lundberg O; Kallner HK; Danielsson KG; Trussell J; Scherwitzl R
Article: FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY. 2017;23(5):318-323
Transurethral Polyacrylamide Hydrogel Injection Therapy in Women Not Eligible for Midurethral Sling Surgery
Altman D; Ghilotti F; Bellocco R; Zetterstrom J; Kallner HK
Article: GYNECOLOGIC AND OBSTETRIC INVESTIGATION. 2017;82(2):144-150
Persistence of Lactobacilli in Postmenopausal Women - A Double-Blind, Randomized, Pilot Study
Kwak Y-K; Daroczy K; Colque P; Kuhn I; Mollby R; Kallner HK
Article: MENOPAUSE. 2016;23(12):1303-1306
Hormonal influence on the effect of mirabegron treatment for overactive bladder
Kallner HK; Elmer C; Andersson K-E; Altman D
Article: HUMAN REPRODUCTION. 2016;31(11):2484-2490
Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial
Hognert H; Kallner HK; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2016;95(8):887-893
Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate - a prospective observational cohort study
Envall N; Kofoed NG; Kopp-Kallner H
Article: EUROPEAN JOURNAL OF OBSTETRICS AND GYNECOLOGY AND REPRODUCTIVE BIOLOGY. 2016;203:167-172
Safety and efficacy of mirabegron in daily clinical practice: a prospective observational study
Kallner HK; Christensson AA; Elmer C; Flam B; Altman D
Article: PLOS ONE. 2016;11(6):e0158645
Medical Abortion Provided by Nurse-Midwives or Physicians in a High Resource Setting: A Cost-Effectiveness Analysis
Sjostrom S; Kallner HK; Simeonova E; Madestam A; Gemzell-Danielsson K
Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2015;94(8):884-890
Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden
Henry N; Hawes C; Lowin J; Lekander I; Filonenko A; Kallner HK
Article: HUMAN REPRODUCTION. 2015;30(6):1314-1322
Sublingual versus vaginal misoprostol for cervical dilatation 1 or 3 h prior to surgical abortion: a double-blinded RCT
Saav I; Kallner HK; Fiala C; Gemzell-Danielsson K
Article: BJOG: AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY. 2015;122(4):510-517
The efficacy, safety and acceptability of medical termination of pregnancy provided by standard care by doctors or by nurse-midwives: a randomised controlled equivalence trial
Kallner HK; Gomperts R; Salomonsson E; Johansson M; Marions L; Gemzell-Danielsson K
Article: PLOS ONE. 2015;10(5):e0125990
Use of Contraception and Attitudes towards Contraceptive Use in Swedish Women - A Nationwide Survey
Kallner HK; Thunell L; Brynhildsen J; Lindeberg M; Danielsson KG
Article: INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2015;31(3):181-187
DIAGNOSTIC COLPOSCOPIC ACCURACY BY THE GYNOCULAR AND A STATIONARY COLPOSCOPE
Kallner HK; Persson M; Thuresson M; Altman D; Shemer I; Thorsell M; Shemer EAW
Article: INTERNATIONAL JOURNAL OF GYNECOLOGY AND OBSTETRICS. 2014;126:S52-S55
Contraception following abortion and the treatment of incomplete abortion
Gemzell-Danielsson K; Kallner HK; Faundes A
Article: CONTRACEPTION. 2012;86(4):419-424
Effect of letrozole on uterine tonus and contractility: A randomized controlled trial
Kallner HK; Ho PC; Gemzell-Danielsson K
Article: CONTRACEPTION. 2012;85(4):394-397
Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion
Kallner HK; Fiala C; Gemzell-Danielsson K
Article: HUMAN REPRODUCTION. 2010;25(5):1153-1157
Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days
Kallner HK; Fiala C; Stephansson O; Gemzell-Danielsson K
Show more

All other publications

Review: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2024;29(2):40-52
Health benefits of combined oral contraceptives - a narrative review
Bennink HJTC; van Gennip FAM; Gerrits MGF; Egberts JFM; Gemzell-Danielsson K; Kopp-Kallner H
Editorial comment: EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE. 2022;27(4):271
June 24th, 2022: once a right is obtained, it can no longer be lost!
Kallner HK; Grandi G
Letter: CONTRACEPTION. 2018;97(5):456-457
Clarifications concerning contraceptive mobile app Pearl Index calculations
Lundberg O; Scherwitzl EB; Scherwitzl R; Kallner HK; Danielsson KG; Trussell J
Review: F1000RESEARCH. 2018;7:F1000 Faculty Rev-973-973
Benefits of reversible contraception.
Kopp Kallner H
Review: UPSALA JOURNAL OF MEDICAL SCIENCES. 2016;121(4):252-255
Prevention of unintended pregnancy and use of contraceptionimportant factors for preconception care
Kallner HK; Danielsson KG
Thesis / dissertation: 2012
Increasing access to medical abortion
Kopp Kallner, Helena

Employments

Senior Lecturer/Senior Physician, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2022-

Degrees and Education

Docent, Karolinska Institutet, 2017
Degree Of Doctor Of Philosophy, Department of Women's and Children's Health, Karolinska Institutet, 2012
University Medical Degree, Karolinska Institutet, 2000

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI